(Q62024924)

English

An Evaluation of the Safety and Efficacy of NTZ on Collagen Turnover in NASH Patients With Fibrosis

clinical trial

In more languages

edit

Statements

instance of

clinical trial

0 references

title

A Monocentric, Open-Label, Proof of Concept Study to Evaluate the Safety and Efficacy of NTZ at 500mg Twice Daily on Collagen Turnover in Plasma in NASH Patients With Fibrosis Stage 2 or 3 (English)

0 references

medical condition

metabolic dysfunction–associated steatotic liver disease

0 references

liver cirrhosis

0 references

country

United States of America

0 references

start time

15 December 2018

0 references

end time

December 2019

0 references

number of participants

20

0 references

research intervention

nitazoxanide

0 references

clinical trial phase

phase II clinical trial

0 references

research subject recruitment status

recruiting

0 references

minimum age

18 year

0 references

maximum age

75 year

0 references

study type

interventional study

0 references

Identifiers

ClinicalTrials.gov ID

NCT03656068

0 references

(Q62024924)

An Evaluation of the Safety and Efficacy of NTZ on Collagen Turnover in NASH Patients With Fibrosis

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)